荧光标记的替尔曼诺塞普引导口腔前哨淋巴结定位:在口腔癌兔模型中的研究
本研究在21只健康雄性新西兰兔口腔癌模型中评估荧光标记的替尔曼诺塞普用于前哨淋巴结活检的可行性。荧光成像与放射性计数的一致率为98.0%,Cohen kappa系数为0.879;48小时延迟活检一致率为97.8%,kappa系数为0.884。荧光标记的Tc-99m替尔曼诺塞普可作为提高口腔癌前哨淋巴结活检准确性的辅助手段。
要点
- 颊黏膜注射均出现同侧前哨淋巴结引流,舌注射有18.2%出现对侧引流。
- 荧光与放射性计数识别前哨淋巴结的一致率为98.0%,Cohen kappa系数为0.879。
- 48小时延迟前哨淋巴结活检的一致率为97.8%,Cohen kappa系数为0.884。
核心结论
- 荧光标记的Tc-99m替尔曼诺塞普可作为提高口腔癌前哨淋巴结活检准确性的高精度辅助手段。
研究设计与样本
- 动物研究,使用21只健康雄性新西兰兔建立口腔癌模型。
- 将镓-68标记的替尔曼诺塞普用IRDye800CW标记后,黏膜下注射至颊黏膜(n=6)或侧舌(n=7),随后进行PET成像。
- 注射1小时后,使用荧光成像进行前哨淋巴结活检,随后行双侧颈淋巴结清扫并采集非淋巴结周围组织。
- 所有组织测量放射性和荧光。
- 另有8只兔子在注射后48小时进行延迟前哨淋巴结活检。
主要发现
- 颊部注射均出现同侧前哨淋巴结引流,舌部注射有18.2%出现对侧引流。
- 平均识别1.9±1.0枚前哨淋巴结(范围1-5枚)。
- 每只动物平均切除16.9±3.3枚非前哨淋巴结。
- 前哨淋巴结平均放射性为注射剂量的0.69±0.60%,非前哨淋巴结为0.012±0.025%,周围组织为0.0067±0.015%。
- 荧光与放射性识别前哨淋巴结的一致率为98.0%,Cohen kappa系数为0.879;48小时延迟活检一致率为97.8%,Cohen kappa系数为0.884。
临床怎么用
- 作者认为荧光标记的Tc-99m替尔曼诺塞普可作为提高口腔癌前哨淋巴结活检准确性的高精度辅助手段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: With the shift toward utilization of sentinel lymph node biopsy (SLNB) in oral cavity cancer, improved techniques for intraoperative sentinel node identification are needed. This study investigates the feasibility of fluorescently labeled tilmanoscept in SLNB in an oral cancer rabbit model. METHODS: An animal study was designed using 21 healthy male New Zealand rabbits. Gallium-68-labeled tilmanocept labeled with IRDye800CW was injected submucosally into the buccal mucosa (n = 6) or lateral tongue (n = 7) followed by PET imaging. One hour after injection, SLNB was performed using fluorescence imaging followed by a bilateral neck dissection and sampling of non-nodal surrounding tissue. All tissues were measured for radioactivity and fluorescence. In addition, eight rabbits were injected with delayed SLNB performed 48 h after injection. RESULTS: Buccal injections all had ipsilateral SLN drainage and tongue injections exhibited 18.2% contralateral drainage. An average of 1.9 ± 1.0 SLN (range 1-5) were identified. In addition, an average of 16.9 ± 3.3 non-sentinel lymph nodes were removed per animal. SLNs had an average of 0.69 ± 0.60 percent-of-injected dose (%ID) compared with non-sentinel nodes with 0.012 ± 0.025 %ID and surrounding tissue with 0.0067 ± 0.015 %ID. There was 98.0% agreement between sentinel lymph nodes identified using fluorescence compared to radioactivity with Cohen's kappa coefficient of 0.879. In 48-h delayed SLNB, results were consistent with 97.8% agreement with radioactivity and Cohen's Kappa coefficient of 0.884. Fluorescence identified additional lymph nodes that were not identified by radioactivity, and with one false negative. CONCLUSION: Fluorescent-labeled Tc-99 m-tilmanocept represents a highly accurate adjunct to enhance SLNB for oral cavity cancer. LEVEL OF EVIDENCE: N/A Laryngoscope, 134:1299-1307, 2024.
引用
- Guo T, Jang SS, Ogawa R, et al. Fluorescent Guided Sentinel Lymph Mapping of the Oral Cavity with Fluorescent-Labeled Tilmanocept. Laryngoscope. 2023. PMID: 37668315. doi:10.1002/lary.31014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。